A new human extrahepatic bile duct carcinoma cell line (TFK-1) was established from a surgically resected tumor specimen, which was histologically diagnosed as partly papillary adenocarcinoma and partly differentiated tubular adenocarcinoma. The tumor cells cultured in RPMI-1640 medium supplemented with 10% FBS grew as monolayers showing epithelial-like morphology with a population doubling time of 37 hr during exponential growth at passage 40. Chromosome number was distributed in the range of 72 to 76, with a modal number of 73. Tumor markers (CEA, CA19-9, ST-439, DUPAN-2) were negative in culture supernatant and plasma of SCID mice grafted with TFK-1 cells. Though no point mutation at 12 colon of K-ras was detected, expression of c-erbB-2 product and MUC 1 antigen was positive. TFK-1 is the third cell line established from extrahepatic bile duct carcinomas in the world literature, and should provide useful information on various aspects of this type of neoplasm.
better understanding of its biology. However, only a limited number of BDC cell lines have so far been established, and this is especially true for the extrahepatic BDC case.
In this paper, we report the establishment of a new extrahepatic BDC cell line, TFK-1, cultured directly from surgically resected tumor tissue.
MATERIALS AND METHODS

Patient
A 63-year-old male, complaining of jaundice and general malaise, was hospitalized in our clinic. He received partial resection of the bile duct, cholecystectomy and right lobectomy of the liver. The main tumor was located in the middle of the common bile duct, where lumen was occupied by a soft papillary mass. Histologically, the tumor mainly consisted of papillary elements, but in parts demonstrated features of a moderately differentiated tubular adenocarcinoma ( Fig. 1) . Serum tumor marker levels on admission were as follows: CEA, 4 ng/ml; CA19-9,11 U/ml; AFP, 4 ng/ml. These values were within the normal ranges.
Cell culture A specimen, obtained at surgical operation from the main tumor, was cut into pieces, digested with 1,000 U/ml Dispase (Collaborative Research, Bedford, MA, USA) for 30 min at 37°C and the large tissue fragments allowed to settle. Supernatant fluid containing dissociated cells was collected, centrifuged at 100 x g and the cell pellets were resuspended in RPMI-1640 containing 10% fetal bovine ery. It tubular serum (FBS), 100 U/ml penicillin, and 100 jig/ml streptomycin. Culture was in 12-well plates (Costar, Cambridge, MA, USA) in a 5% CO2 incubator at 37°C. Initially, contaminating fibroblast cells were found in the cultures, but after serial passage for about 6 months, remaining fibroblasts could be removed by mechanical scraping and differential attachment selection with trypsin. Thereby, a BDC cell line, designated TFK-1, forming typical epithelial monolayers was obtained. The TFK-1 cells have been serially cultured for 44 months (75 passages) since the primary culture in our laboratory.
Heterologous transplantation
Growing culture cells were harvested with trypsin (0.25%)/EDTA (0.02%), washed and suspended in PBS. The cells (1 x 10') were then injected s.c. into the backs of CB17/Icr-SCID, Jcl mice (female, 7-week-old). Under anesthesia, the mice bearing tumors were autopsied and the tumor tissues were examined histologically.
Karyotype analysis
Chromosomal analysis was performed on metaphase cells prepared by treatment with 0.05 mg/ml colcemid for 12 hr. The cells were subjected to hypotonic conditions for 15 min, then fixed in methanol: acetic acid (3: 1) solution. The treated cells were smeared on slide-glasses and air-dried slides were G-banded for analysis.
Cell growth analysis
Growth rate of the TFK-1 cell line at passage 40 was examined by seeding 35-mm cell culture dishes with 2 x 105 cells/dish in 2 ml of RPMI-1640 supplemented with 10% FBS. The cells were counted in triplicate every day with a hemocytometer. Doubling time was calculated using a semilogarithmic graph.
Tumor markers secreted by TFK-1 cells
To examine for secretion of tumor markers into the culture medium, confluently growing TFK-1 cells were cultured for 2 days. Then, collected supernatant was assayed for tumor markers including CEA, CA19-9, ST-439 and DUPAN-2 by radioimmunoassay. Plasma from TFK-1 xenografted SCID mice, which were sacrificed when subcutaneous tumor size was about 1.5 x 1.5 cm, was also assayed for the tumor markers by the same method.
Mutation analysis of the K-ras gene
Initially, DNA was isolated from TFK-1 cells (1 x 107) by the phenolchloroform extraction method. Oligonucleotide primers used for PCR amplification of K-ras were as follows; K-ras-HindIII (5'-GGGA/ AGCTTGTGGTAGTTGGAGC-3') K-ras-EcoRI (5'-CCCG/AATTCCTG CACCAGTAATATGCA-3'). Genomic DNA was amplified by PCR using the above two primers, and the PCR products were digested with HindIIl and EcoRI. Then, they were ligated into plasmid vector pUC18. The vector was transfected to E, coli (DH5a strain), and six clones were obtained. To identify K-ras mutations at codon 12, we subsequently sequenced K-ras exon containing amplified fragments by the dideoxy chain termination method.
Immunohistological study of the c-erbB-2 product Xenograft TFK-1 tumors were fixed in neutral formalin and embedded in paraffin. Tissue sections (4 ,um thick), after deparaffinization, were treated with 0.3% 11202 in methanol and incubated with rabbit polyclonal anti-c-erbB-2 product (31004; Nichirei, Tokyo). Then, they were incubated with biotinylated anti-rabbit IgG, followed by incubation with ABC complex (Vector Lab. Inc., Burlingame, CA, USA). The sections were developed with substrate solution which contained 3, 3'-diaminobenzidine and 11202.
FRCS analysis of M UCI expression
MUC1 expression on the surfaces of TFK-1 cells was examined by indirect membrane immunofluorescence tests using Muse-11 monoclonal antibody (kindly supplied by Dr. Imai, Sapporo Medical College), and FITC conjugated anti-mouse IgG (EY Lab., San Mateo, CA, USA) as the second antibody. The stained cells were analyzed by flow cytometry (FACSsort, Beckton Dickinson, Lincoln Park, NJ, USA).
Morphologic study
Tissue sections of the BDC tumor obtained at surgery and xenografted tumors were stained with hematoxylin and eosin (H & E). Monolayer cells after fixation with 2% glutaraldehyde were processed by routine methods for transmission electron microscopy (TEM).
RESULTS
Morphological characteristics of cultured TFK-1 cells Fig. 2 shows the typical morphological features of TFK-1 cells on a plastic dish, with formation of polygonal epithelial monolayers showing a pavement stone-like arrangement.
Electron microscopic findings
Ultrastructural observation by TEM revealed the cells to contain irregular orthochromatic nuclei and to be relatively rich in mitochondria and ribosomes, with moderate amounts of rough endoplasmic reticulum and microfilaments (tonofilaments). On the surfaces of the cells, pseudopods and numerous microvilli were evident (Fig. 3) . range of 72-76 (Fig. 5) . A representative G-banded karyotype is shown in Fig. 6 , exhibiting some common structural changes. Abnormalities of i (lq), dup (1) (p22 p32), t (1; 9) (p13 : p21), del (3) (pl3 p21), t (6; 9) (qll ; qll), t (11:15) (p11, p11) were found in 100% of the cells, of i (15q), i (17q), i (21q) in 90%, and of del (11) (p11) in 60% (Fig. 6 ).
Hetero traps p lan tation
With an inoculum of 1 x 107 cells, progressively growing tumors were regular- (1) ly observed in SCID mice. Light microscopy of the xenografted tumor specimens, obtained one month after inoculation, demonstrated the same morphology as the surgically resected BDC tumor, that is, the main component was invasive papillary adenocarcinoma accompanied by the areas of moderately differentiated solid structures (Fig. 7) . Expression of c-erbB-2 product was weakly demonstrated by immunohistological investigation of xenograft tumor tissue (Fig. 8) . Expression of c-erbB-2 protein was detected immunohistochemically, using a rabbit anti-c-erbB-2 polyclonal antibody specific for the intracellular domain of the protein (Nichirei Co., Inc., Tokyo). Secretion of tumor markers In Table 1 , tumor marker levels are shown. Two tumor markers (CEA and CA19-9) in the patient's plasma taken at admission were within normal range. In the plasma of tumor-bearing SCID mice, no increase in CEA or CA19-9 was found. Similarly, four tumor markers (CEA, CA19-9, ST-439, and DUPAN-2) did not show positive values in the TFK-1 culture supernatant. 
DISCUSSION
In the present study, we succeeded in establishing a new human extrahepatic BDC cell line from a surgically resected specimen, without xenotransplantation. The cell line shows the typical morphology of polygonal epithelial monolayers with a pavement stone-like cell arrangement. The electron microscopic demonstration of numerous microvilli on the luminar cell surfaces, with bundles of intracytoplasmic tonofilaments, further confirms a typical epithelial cell phenotype. Although secretion of tumor markers (CEA, CA19-9, ST-439, DUPAN-2) from TFK-1 cells was not detected, expression of c-erbB-2 product and MUC1 antigen (Yamashita et al. 1993 ) was positive. In addition the histology of xenotransplanted lesion closely resembled that of the original surgically resected tumor. These results indicate that the TFK-1 cell line is indeed derived from SK-ChA-1 was established from malignant ascites with primary adenocarcinoma of the extrahepatic biliary tree, and KMBC was established from a serially transplanted tumor in nude mouse. Most culture cell lines established from xenografted tumor tissues are known to be infected with murine C-type viruses, while TFK-1 cell line has been established from surgically resected tumor specimen. The method applied for establishment of the cell line should give more value to TFK-1 cell line.
KMBC cells, originated from well-differentiated adenocarcinoma, possess various functional characteristics, such as CA19-9, tissue peptide antigen, CEA, ferritin, R2-microglobulin, fibronectin and a2-macroglobulin. Contrary, TFK-1 cells secrete neither CA19-9 nor CEA. The difference between the two cell lines might be related to differentiation stage of the two BDC tissues.
According to a recent paper (Imai et al. 1994 ), K-ras colon 12 mutations are detectable in a high proportion of bile duct tumors (13 of 23, 56.5%) when tumor samples are obtained by microdissection from paraffin-embedded tissue sections. However, K-ras mutations do not appear to be correlated with tumor size, histologic type or metastatic potential (Imai et al 1994) . In the present study, TFK-1 was not found to show K-ras colon 12 mutation, but the fact that it does express c-erbB2 product, and MUC 1 antigen, is of interest in terms of studies of BDC carcinogenesis.
